NGSX 13F Hedge Fund and Asset Management Owners

Data derived from most recent annual or quarterly report
Market Cap	133.32 Thousand	Shares Outstanding	33.33 Million	Avg 30-day Volume	42.876 Thousand
P/E Ratio	0.0	Dividend Yield	0.0	EPS	-0.11
Price to Revenue	0.5921	Debt to Equity	-0.8803	EBITDA	-15.841 Million
Price to Book Value	0.0	Operating Margin	-155.5104	Enterprise Value	62.465 Million
Current Ratio	1.045	EPS Growth	0	Quick Ratio	0.97
1 Yr BETA	-2.935	52-week High/Low	0.0 /	Profit Margin	-259.6634
Operating Cash Flow Growth	34.1426	Free Cash Flow to Firm (FCFF) TTM	0	Free Cash Flow to Equity (FCFE) TTM	-12.506 Million
Altman Z-Score	-25.2216

Funds Holding NGSX (via 13F filings)

Quarter to view: Refresh Download CSV Download Excel (.xlsx) Download TSV

Market Value:

Ranking:

% of portfolio

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NGSX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

4: filed on 2013-01-03 by NEUROGESX INC

4: filed on 2012-12-04 by GHIGLIERI STEPHEN F

4: filed on 2012-11-14 by PEROUTKA STEPHEN J

4/A: filed on 2012-09-19 by MARKELS MICHAEL

4: filed on 2012-09-05 by MARKELS MICHAEL

4: filed on 2012-09-05 by GHIGLIERI STEPHEN F

4: filed on 2012-08-07 by MARKELS MICHAEL

4: filed on 2012-08-07 by GHIGLIERI STEPHEN F

4: filed on 2012-06-11 by NEUROGESX INC

4: filed on 2012-06-11 by ORWIN JOHN A

Events (8k)

Proposed Sales (Form 144)

Proxy

Prospectus

All

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name	Type	Last Reported Shares Held	Last Reported Date
MARTELL RON PRESIDENT AND CEO	Officer	25,000	2013-01-01
GHIGLIERI STEPHEN F EXEC. V.P., COO & CFO	Officer	86,293	2012-12-01
PEROUTKA STEPHEN J VICE PRESIDENT AND CMO	Officer	18,750	2012-11-09
MARKELS MICHAEL SENIOR VP,COMMERCIAL & BUS DEV	Officer	71,206	2012-09-01
LYONS GARY A	Director	0	2012-06-07
NELSEN ROBERT	Director 10% Owner	0	2012-06-07
GOODWIN BRADFORD S	Director	0	2012-06-07
NELSON STEVEN H	Director	0	2012-06-07
KURTZ NEIL M	Director	0	2012-06-07
ORWIN JOHN A	Director	0	2012-06-07
BIENAIME JEAN JACQUES	Director	0	2012-02-07
DITONNO ANTHONY A PRESIDENT & CEO	Officer Director	107,283	2011-12-12
TOBIAS JEFFREY K CMO, EVP RESEARCH & DEVE	Officer	4,999	2011-09-16
ARKIN MOSHE M. ARKIN (1999) LTD.	10% Owner ALSO MEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUP	No longer subject to file	2011-08-09
BREEN DORON SPHERA FUNDS MANAGEMENT LTD. MOR ISRAEL SENATOR RON	MEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUPMEMBER OF 10% OWNER GROUP	No longer subject to file	2011-08-09
ARCH VENTURE FUND V LP ARCH VENTURE PARTNERS V LP ARCH VENTURE PARTNERS V LLC CRANDELL KEITH BYBEE CLINTON LAZARUS STEVEN NELSEN ROBERT	Director 10% Owner	5,059,870	2011-07-21
BLEY KEITH R SVP, NONCLINICAL R & D	Officer	0	2011-02-03
RINNE SUSAN P VICE PRESIDENT, REGULATORY	Officer	0	2011-02-03
KAWAHATA RUSSELL T VP, PHARMACEUTICAL SCIENCE	Officer	0	2011-02-03
ARKIN MOSHE	10% Owner ALSO MEMBER OF 10% OWNER GROUP	2,648,107	2010-09-09
SVLSF IV, LLC SV LIFE SCIENCES FUND IV LP SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS L P SV LIFE SCIENCES FUND IV (GP), L.P.	10% Owner	61,324	2010-05-03
FLYNN JAMES E DEERFIELD CAPITAL LP DEERFIELD SPECIAL SITUATIONS FUND, L.P. DEERFIELD MANAGEMENT CO /NY DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTD	10% Owner POSSIBLE MEMBER OF 10% GROUP	No longer subject to file	2009-07-13
PEACOCK BRUCE	Director	0	2009-05-28
HARDER KAREN J SVP, REG AFFAIRS	Officer	30,065	2007-10-02
MARDUEL ALIX	Director 10% Owner	5,000	2007-06-05
TURNER DANIEL K III	Director	5,000	2007-06-05
ARCH VENTURE FUND V LP ARCH V ENTREPRENEURS FUND LP HEALTHCARE FOCUS FUND LP ARCH VENTURE PARTNERS V LP ARCH VENTURE PARTNERS V LLC CRANDELL KEITH BYBEE CLINTON LAZARUS STEVEN	10% Owner	2,531,328	2007-05-07
ARCH VENTURE FUND V LP ARCH VENTURE PARTNERS V LP ARCH VENTURE PARTNERS V LLC CRANDELL KEITH BYBEE CLINTON LAZARUS STEVEN	10% Owner	227,000	2007-05-02
PACVEN WALDEN MANAGEMENT V CO. LTD. PACVEN WALDEN VENTURES V LP PACVEN WALDEN VENTURES PARALLEL V-A C.V. PACVEN WALDEN VENTURES PARALLEL V-B C.V. PACVEN WALDEN VENTURES V QP ASSOCIATES FUND LP PACVEN WALDEN VENTURES V ASSOCIATES FUND LP TAN LIP BU KAU ANDREW COLEMAN MARY	10% Owner SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS	0	2007-05-01
IVCIC-WALDEN MANAGEMENT CO LTD. INTERNATIONAL VENTURE CAPITAL INVESTMENT III CORP ASIAN VENTURE CAPITAL INVESTMENT CORP INTERNATIONAL VENTURE CAPITAL INVESTMENT CORP TAN LIP BU LOO HOCK VOON	SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS	0	2007-05-01
WALDEN INTERNATIONAL SINGAPORE PTE LTD. SEED VENTURES III PTE LTD. TAN LIP BU LOO HOCK VOON	SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS	0	2007-05-01
MARDUEL ALIX ALTA CALIFORNIA MANAGEMENT PARTNERS II LLC ALTA CALIFORNIA MANAGEMENT PARTNERS II, LLC -- NEW POOL ALTA CALIFORNIA PARTNERS II LP ALTA CALIFORNIA PARTNERS II, L.P. -- NEW POOL ALTA EMBARCADERO PARTNERS II LLC DELEAGE JEAN GRUENER GARRETT JANNEY DANIEL NOHRA GUY P	Director 10% Owner	0	2007-05-01
MONTREUX EQUITY PARTNERS II SBIC LP MONTREUX EQUITY MANAGEMENT II SBIC LLC PALEFSKY HOWARD D TURNER DANIEL K III CHAPEKAR MANISH SAVARESE JOHN	Director SEE GENERAL REMARKSSEE GENERAL REMARKSSEE GENERAL REMARKSSEE GENERAL REMARKSSEE GENERAL REMARKSSEE GENERAL REMARKS	0	2007-05-01
MONTREUX EQUITY MANAGMENT III SBIC TURNER DANIEL K III PALEFSKY HOWARD D CHAPEKAR MANISH SAVARESE JOHN	Director SEE GENERAL REMARKSSEE GENERAL REMARKSSEE GENERAL REMARKSSEE GENERAL REMARKSSEE GENERAL REMARKS	0	2007-05-01
ALTA BIOPHARMA MANAGEMENT III LLC ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG ALTA BIOPHARMA PARTNERS III LP ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC CHAMPSI FARAH HURWITZ EDWARD PENHOET EDWARD	10% Owner	0	2007-05-01

Insider Transactions Last 60 Days

Reporting Owners	Filing Date	Trans Date	Trans Code	Shares	Share Price	Acquired Disposed	Shares Owned after	D/I	10b5	Perf 1d*	Perf 5d*	Perf 1m*	Max Gain	Max Gain Days	Max Loss	Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code	Definition
A	Grant, award or other acquisition pursuant to Rule 16b-3(d)
C	Conversion of derivative security
D	Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E	Expiration of short derivative position
F	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G	Bona fide gift
H	Expiration (or cancellation) of long derivative position with value received
I	Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J	Other acquisition or disposition
L	Small acquisition under Rule 16a-6
M	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O	Exercise of out-of-the-money derivative security
P	Open market or private purchase of non-derivative or derivative security
S	Open market or private sale of non-derivative or derivative security
U	Disposition pursuant to a tender of shares in a change of control transaction
W	Acquisition or disposition by will or the laws of descent and distribution
X	Exercise of in-the-money or at-the-money derivative security
Z	Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security	Date/Time	Rebate Rate	Fee Rate	Shares Available

Current Active Short Positions

Holder	Issuer	Net Short Position	Position Date	Origin

NEUROGESX, INC. (DELAWARE) YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

NEUROGESX, INC. (DELAWARE) (NGSX)

Funds Holding NGSX (via 13F filings)

Filter by:

Mutual Funds Holding NGSX

Active Schedule 13D and 13G filings

Recent Filings

Financial Reporting

Ownership

Events (8k)

Proposed Sales (Form 144)

Proxy

Prospectus

All

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

Open Market Sells (S)

Exercise Derivative Conversion (M)

Current/Former Insiders

Insider Transactions Last 60 Days

IBR Securities Loan Availability

Current Active Short Positions

No recent transactions

* To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page*

Elevate your investments

NEUROGESX, INC. (DELAWARE) (NGSX)

Funds Holding NGSX (via 13F filings)

Filter by:

Mutual Funds Holding NGSX

Active Schedule 13D and 13G filings

Recent Filings

Financial Reporting

Ownership

Events (8k)

Proposed Sales (Form 144)

Proxy

Prospectus

All

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

Open Market Sells (S)

Exercise Derivative Conversion (M)

Current/Former Insiders

Insider Transactions Last 60 Days

IBR Securities Loan Availability

Current Active Short Positions

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments

* To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page*